STAT1 and systemic sclerosis: Similar to TBK inhibition, tofacitinib completely blocked the SSc fibroblast exosome–mediated STAT1 activation in HaCaTs (Figure 6D and E) as well as ISG expression (Figure 6F), suggesting that the observed type I IFN response is mediated by activation of JAK.